| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 9891* | 2016 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1736-1788, 2018 | 7653 | 2018 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 7382 | 2015 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The lancet 388 (10053), 1545-1602, 2016 | 6641* | 2016 |
| Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 VL Feigin, E Nichols, T Alam, MS Bannick, E Beghi, N Blake, ... The Lancet Neurology 18 (5), 459-480, 2019 | 4810* | 2019 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 2558* | 2015 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 VL Feigin, BA Stark, CO Johnson, GA Roth, C Bisignano, GG Abady, ... The Lancet Neurology 20 (10), 795-820, 2021 | 2524 | 2021 |
| Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 ER Dorsey, A Elbaz, E Nichols, N Abbasi, F Abd-Allah, A Abdelalim, ... The Lancet Neurology 17 (11), 939-953, 2018 | 2462 | 2018 |
| Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 E Nichols, CEI Szoeke, SE Vollset, N Abbasi, F Abd-Allah, J Abdela, ... The Lancet Neurology 18 (1), 88-106, 2019 | 2410 | 2019 |
| Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 LJ Stovner, E Nichols, TJ Steiner, F Abd-Allah, A Abdelalim, ... The Lancet Neurology 17 (11), 954-976, 2018 | 1804 | 2018 |
| Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 CO Johnson, M Nguyen, GA Roth, E Nichols, T Alam, D Abate, ... The Lancet Neurology 18 (5), 439-458, 2019 | 1650 | 2019 |
| MRI-guided thrombolysis for stroke with unknown time of onset G Thomalla, CZ Simonsen, F Boutitie, G Andersen, Y Berthezene, ... New England Journal of Medicine 379 (7), 611-622, 2018 | 1400 | 2018 |
| Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase M Endres, U Laufs, Z Huang, T Nakamura, P Huang, MA Moskowitz, ... Proceedings of the National Academy of Sciences 95 (15), 8880-8885, 1998 | 1252 | 1998 |
| Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis U Laufs, N Werner, A Link, M Endres, S Wassmann, K Jürgens, E Miche, ... Circulation 109 (2), 220-226, 2004 | 1220 | 2004 |
| Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia S Namura, J Zhu, K Fink, M Endres, A Srinivasan, KJ Tomaselli, J Yuan, ... Journal of Neuroscience 18 (10), 3659-3668, 1998 | 1188 | 1998 |
| Rivaroxaban for stroke prevention after embolic stroke of undetermined source RG Hart, M Sharma, H Mundl, SE Kasner, SI Bangdiwala, SD Berkowitz, ... New England Journal of Medicine 378 (23), 2191-2201, 2018 | 1055 | 2018 |
| Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global … N Fullman, J Yearwood, SM Abay, C Abbafati, F Abd-Allah, J Abdela, ... The Lancet 391 (10136), 2236-2271, 2018 | 858 | 2018 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990 … GBD 2013 Risk Factors Collaborators Lancet (London, England) 386 (10010), 2287, 2015 | 835* | 2015 |
| Ischemic brain injury is mediated by the activation of poly (ADP-ribose) polymerase M Endres, ZQ Wang, S Namura, C Waeber, MA Moskowitz Journal of Cerebral Blood Flow & Metabolism 17 (11), 1143-1151, 1997 | 789 | 1997 |
| The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 FA Klok, GJAM Boon, S Barco, M Endres, JJM Geelhoed, S Knauss, ... European Respiratory Journal 56 (1), 2020 | 766 | 2020 |
jochen b. fiebachHead of CSB Neuroradiology, Center for Stroke Research Berlin, Charité Berlin, GermanyBestätigte E-Mail-Adresse bei charite.de